Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease

View ORCID ProfileOriol Mitja, Maria Ubals, Marc Corbacho, Andrea Alemany, Clara Suner, Cristian Tebe, Aurelio Tobias, Judith Penafiel, Ester Ballana, Carla A Perez, Pol Admella, Nuria Riera-Marti, Pep Laporte, Jordi Mitja, Mireia Clua, Laia Bertran, Sergi Gavilan, Jordi Ara, Maria Sarquella, Josep M Argimon, Gabriel Cuatrecasas, Paz Canadas, Aleix Elizalde-Torrent, Robert Fabregat, Magi Farre, Anna Forcada, Gemma Flores-Mateo, Cristina Lopez, Esteve Muntada, Nuria Nadal, Silvia Narejos, Aroa N Gil-Ortega, Nuria Prat, Jordi Puig, Carles Quinones, Ferran Ramirez-Viaplana, Juliana Reyes-Uruena, Eva Riveira-Munoz, Lidia Ruiz, Sergi Sanz, Alexis Sentis, Alba Sierra, Cesar Velasco, Rosa Maria Vivanco-Hidalgo, Juani Zamora, Jordi Casabona, Marti Vall-Mayans, Camila G-Beiras, Bonaventura Clotet
doi: https://doi.org/10.1101/2020.07.20.20157651
Oriol Mitja
1 1. Fight AIDS and Infectious Diseases Foundation, Badalona, Spain 2. Hospital Universitari Germans Trias i Pujol, Badalona Spain 3. Lihir Medical Centre-InternationalSOS, Lihir Island, Papua New Guinea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oriol Mitja
  • For correspondence: omitja@flsida.org
Maria Ubals
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mubals@flsida.org
Marc Corbacho
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marc.corbach@gmail.com
Andrea Alemany
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrealemany89@gmail.com
Clara Suner
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: clarasuner@gmail.com
Cristian Tebe
3 Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ctebe@idibell.cat
Aurelio Tobias
4 Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research (CSIC), Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aurelio.tobias@gmail.com
Judith Penafiel
3 Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jpenafiel@idibell.cat
Ester Ballana
5 IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eballana@irsicaixa.es
Carla A Perez
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carla.alvarez.perez@gmail.com
Pol Admella
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: poladmellaclanchet@gmail.com
Nuria Riera-Marti
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nuria.rima@gmail.com
Pep Laporte
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: peplaporte@hotmail.com
Jordi Mitja
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jordimitjav@gmail.com
Mireia Clua
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mclua@kwanbarcelona.com
Laia Bertran
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lbertran@flsida.org
Sergi Gavilan
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sgavilan@flsida.org
Jordi Ara
6 Hospital Universitari Germans Trias i Pujol, Badalona Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gterritorial.mn.ics@gencat.cat
Maria Sarquella
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: msarquella@flsida.org
Josep M Argimon
7 Direccio-gerencia, Institut Catala de la Salut, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmargimon@gencat.cat
Gabriel Cuatrecasas
8 Equip atencio primaria de Sarria, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gcuatrecasas@capsarria.com
Paz Canadas
9 SYNLAB, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paz.canadas@synlab.es
Aleix Elizalde-Torrent
5 IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aelizalde@irsicaixa.es
Robert Fabregat
10 Direccio General de Recerca i Innovacio en Salut, Generalitat de Catalunya, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robert.fabregat@gencat.cat
Magi Farre
6 Hospital Universitari Germans Trias i Pujol, Badalona Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mfarre.germanstrias@gencat.cat
Anna Forcada
11 Gerencia territorial de Catalunya Central, Institut Catala de la Salut, St. Fruitos de Bages, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aforcada.cc.ics@gencat.cat
Gemma Flores-Mateo
12 Xarxa Santa Tecla Sanitaria i Social. Tarragona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gfloresm@xarxatecla.cat
Cristina Lopez
13 TFS Clinical Contract Research Organization, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cristina.lopez@tfscro.com
Esteve Muntada
14 Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO)-Departament de Salut, Generalitat de Catalunya, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emuntada@iconcologia.net
Nuria Nadal
15 Gerencia territorial de Barcelona, Institut Catala de la Salut, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nnadal.bcn.ics@gencat.cat
Silvia Narejos
16 Entitat de Base Asociativa Centelles- Atencio Primaria, Centelles, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: snarejos@ebacentelles.cat
Aroa N Gil-Ortega
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anieto@flsida.org
Nuria Prat
17 Gerencia territorial de Ambit Metropolita nord, Institut Catala de la Salut, Sabadell, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nprat@gencat.cat
Jordi Puig
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jpuig@flsida.org
Carles Quinones
6 Hospital Universitari Germans Trias i Pujol, Badalona Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cquinonesr.germanstrias@gencat.cat
Ferran Ramirez-Viaplana
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ferranramirez89@gmail.com
Juliana Reyes-Uruena
14 Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO)-Departament de Salut, Generalitat de Catalunya, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmreyes@iconcologia.net
Eva Riveira-Munoz
5 IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eriveira@irsicaixa.es
Lidia Ruiz
5 IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lruiz@irsicaixa.es
Sergi Sanz
18 ISGlobal, Hospital Clinic - Universitat de Barcelona, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sergi.sanz@isglobal.org
Alexis Sentis
14 Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO)-Departament de Salut, Generalitat de Catalunya, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asentisf@iconcologia.net
Alba Sierra
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asierra@flsida.org
Cesar Velasco
19 Agencia de Qualitat i Avaluacio Sanitaries de Catalunya (AQuAS), Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cesarvelasco@gencat.cat
Rosa Maria Vivanco-Hidalgo
19 Agencia de Qualitat i Avaluacio Sanitaries de Catalunya (AQuAS), Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rvivanco@gencat.cat
Juani Zamora
13 TFS Clinical Contract Research Organization, Barcelona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: juani.zamora@tfscro.com
Jordi Casabona
20 Direccio-gerencia, Institut Catala de la Salut, Barcelona, Spain & Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP), Madrid, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jcasabona@iconcologia.net
Marti Vall-Mayans
21 1. Fight AIDS and Infectious Diseases Foundation, Badalona, Spain 2. Hospital Universitari Germans Trias i Pujol, Badalona Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mvall@flsida.org
Camila G-Beiras
2 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cgonzalez@flsida.org
Bonaventura Clotet
22 Fight AIDS and Infectious Diseases Foundation, Badalona, Spain & Hospital Universitari Germans Trias i Pujol, Badalona Spain & Universitat de Vic-Universitat Central de Catalunya (UVIC-UCC), Vic, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bclotet@irsicaixa.es
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are limited to non-pharmacological interventions. Hydroxychloroquine (HCQ) has been proposed as a postexposure therapy to prevent Coronavirus disease 2019 (Covid-19) but definitive evidence is lacking. Methods We conducted an open-label, cluster-randomized trial including asymptomatic contacts exposed to a PCR-positive Covid-19 case in Catalonia, Spain. Clusters were randomized to receive no specific therapy (control arm) or HCQ 800mg once, followed by 400mg daily for 6 days (intervention arm). The primary outcome was PCR-confirmed symptomatic Covid-19 within 14 days. The secondary outcome was SARS-CoV-2 infection, either symptomatically compatible or a PCR-positive result regardless of symptoms. Adverse events (AEs) were assessed up to 28 days. Results The analysis included 2,314 healthy contacts of 672 Covid-19 index cases identified between Mar 17 and Apr 28, 2020. A total of 1,198 were randomly allocated to usual care and 1,116 to HCQ therapy. There was no significant difference in the primary outcome of PCR-confirmed, symptomatic Covid-19 disease (6.2% usual care vs. 5.7% HCQ; risk ratio 0.89 [95% confidence interval 0.54-1.46]), nor evidence of beneficial effects on prevention of SARS-CoV-2 transmission (17.8% usual care vs. 18.7% HCQ). The incidence of AEs was higher in the intervention arm than in the control arm (5.9% usual care vs 51.6% HCQ), but no treatment-related serious AEs were reported. Conclusions Postexposure therapy with HCQ did not prevent SARS-CoV-2 disease and infection in healthy individuals exposed to a PCR-positive case. Our findings do not support HCQ as postexposure prophylaxis for Covid-19.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04304053

Funding Statement

Crowdfunding campaign YoMeCorono (https://www.yomecorono.com/), Laboratorios Rubio, Laboratorios Gebro Pharma, Zurich Seguros, SYNLAB Barcelona, and Generalitat de Catalunya. Laboratorios Rubio also contributed to the study with the required doses of hydroxychloroquine (Dolquine).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol and subsequent amendments were approved by the institutional review board of Hospital Germans Trias Pujol, and the Spanish Agency of Medicines and Medical Devices.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The study protocol and raw data will be available for a year upon request to the corresponding author

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 26, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease
Oriol Mitja, Maria Ubals, Marc Corbacho, Andrea Alemany, Clara Suner, Cristian Tebe, Aurelio Tobias, Judith Penafiel, Ester Ballana, Carla A Perez, Pol Admella, Nuria Riera-Marti, Pep Laporte, Jordi Mitja, Mireia Clua, Laia Bertran, Sergi Gavilan, Jordi Ara, Maria Sarquella, Josep M Argimon, Gabriel Cuatrecasas, Paz Canadas, Aleix Elizalde-Torrent, Robert Fabregat, Magi Farre, Anna Forcada, Gemma Flores-Mateo, Cristina Lopez, Esteve Muntada, Nuria Nadal, Silvia Narejos, Aroa N Gil-Ortega, Nuria Prat, Jordi Puig, Carles Quinones, Ferran Ramirez-Viaplana, Juliana Reyes-Uruena, Eva Riveira-Munoz, Lidia Ruiz, Sergi Sanz, Alexis Sentis, Alba Sierra, Cesar Velasco, Rosa Maria Vivanco-Hidalgo, Juani Zamora, Jordi Casabona, Marti Vall-Mayans, Camila G-Beiras, Bonaventura Clotet
medRxiv 2020.07.20.20157651; doi: https://doi.org/10.1101/2020.07.20.20157651
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease
Oriol Mitja, Maria Ubals, Marc Corbacho, Andrea Alemany, Clara Suner, Cristian Tebe, Aurelio Tobias, Judith Penafiel, Ester Ballana, Carla A Perez, Pol Admella, Nuria Riera-Marti, Pep Laporte, Jordi Mitja, Mireia Clua, Laia Bertran, Sergi Gavilan, Jordi Ara, Maria Sarquella, Josep M Argimon, Gabriel Cuatrecasas, Paz Canadas, Aleix Elizalde-Torrent, Robert Fabregat, Magi Farre, Anna Forcada, Gemma Flores-Mateo, Cristina Lopez, Esteve Muntada, Nuria Nadal, Silvia Narejos, Aroa N Gil-Ortega, Nuria Prat, Jordi Puig, Carles Quinones, Ferran Ramirez-Viaplana, Juliana Reyes-Uruena, Eva Riveira-Munoz, Lidia Ruiz, Sergi Sanz, Alexis Sentis, Alba Sierra, Cesar Velasco, Rosa Maria Vivanco-Hidalgo, Juani Zamora, Jordi Casabona, Marti Vall-Mayans, Camila G-Beiras, Bonaventura Clotet
medRxiv 2020.07.20.20157651; doi: https://doi.org/10.1101/2020.07.20.20157651

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4805)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (765)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)